MedPath

Qualitative Study of Health-seeking and Healthcare Availability in COVID patients

Not yet recruiting
Conditions
Coronavirus as the cause of diseases classified elsewhere,
Registration Number
CTRI/2021/05/033870
Lead Sponsor
Yuvaraj B Chavan
Brief Summary

INTRODUCTION:

The COVID-19 pandemic has disrupted normal life throughout the world since early 2020. India has risen to be the country with the second highest number of cases and third highest number of deaths. A major hurdle in reducing the mortality due to COVID-19 has been a lack of timely access to adequate healthcare, for example due to delays in hospital admission. Another emerging problem has been patients’ preferences for receiving treatment at certain hospitals, leading to those hospitals being overwhelmed with cases despite an overall adequacy in the number of beds available. However, data needs to be gathered to consolidate the so far largely anecdotal evidence of inadequate healthcare delivery. Hence, we have formulated this study to highlight the same in a qualitative analysis and yield further information on issues that require broader, quantitative research to be able to build an effective response to pandemics and crises of the future. AIM:

To qualitatively study the factors influencing healthcare availability and health seeking

behavior of COVID 19 patients at a tertiary care hospital.

OBJECTIVES: 1. To study the social and demographic profile of COVID 19 patients in a tertiary care hospital. 2. To study the facilitating and inhibiting factor s influencing health seeking behavior of COVID 19 patients in a tertiary care hospital.

3.To study the knowledge, attitude, and practices of persons about healthcare availability in the COVID-19 pandemic.

INCLUSION CRITERIA: 1. Patients in the age group of 18 to 60 years. 2. Patients admitted to the COVID 19 ward of our tertiary care hospital for the treatment of COVID 19. 3. Patients who are conscious, co operative, and oriented to time, place, and person and whose health conditions are stable enough to enable them to engage in the in depth interview.

EXCLUSION CRITERIA:

1. Patients who are not mentally stable.

2. Patients not willing to participate.



METHODOLOGY AND ANALYSIS:

This is a qualitative study. It will be commenced after receiving approval from the Institutional Ethics Committee, conducted through semi-structured interviews in the patients’ own words in the COVID wards at the tertiary care hospital. Sampling technique used will be purposive sampling. Patients appearing the most stable in the ward and willing to answer the interview schedule will be enrolled purposively. The sample size is 6 participants, based on the recommendation given by Morse (1994) for phenomenological studies. The interview duration will be 15 to 25 minutes. Before this, participants will be given the Informed Consent Document (ICD) and allotted time to ask questions or doubts. Specific consent will be taken for the audio recording of the interviews by the investigator, for the purpose of analysis. Participation in the study will be at no cost to the participant. Therefore, no compensation will be provided. We plan to conduct this study over a period of 1.5 months. Data gathered in this time will be subsequently analysed by Thematic Content Analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
6
Inclusion Criteria
  • 1.Patients admitted to the COVID-19 ward of our tertiary care hospital for the treatment of COVID-19.
  • 2.Patients who are conscious, co-operative, and oriented to time, place, and person and capable of engaging in the in-depth interview.
Exclusion Criteria
  • 1.Patients who are not mentally stable.
  • 2.Patients not willing to participate.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study will help identify the potential factors influencing health-seeking behavior and outcomes of COVID-19 patients and pinpoint any possible weak links in ensuring good health-seeking behavior, treatment, and outcome of COVID patients, in order to generate research questions for future studies and identify future measures to improve upon these domains.The single time point at which the qualitative data will be analysed will be 4 weeks from the start of the study.
Due to the qualitative nature of the study, no definite outcome measures.The single time point at which the qualitative data will be analysed will be 4 weeks from the start of the study.
Secondary Outcome Measures
NameTimeMethod
This study will help identify the potential factors influencing health-seeking behavior and outcomes of COVID-19 patients and pinpoint any possible weak links in ensuring good health-seeking behavior, treatment, and outcome of COVID patients, in order to generate research questions for future studies and identify future measures to improve upon these domains.Due to the qualitative nature of the study, no definite outcome measures.

Trial Locations

Locations (1)

KEM Hospital

🇮🇳

Mumbai, MAHARASHTRA, India

KEM Hospital
🇮🇳Mumbai, MAHARASHTRA, India
Dr Yuvaraj B Chavan
Principal investigator
9869178407
yuvarajbc@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.